Chapters
Transcript
Why test the combination of Trodelvy and pembrolizumab? Previous efforts testing immunotherapy for HR+ breast cancer has shown disappointing results.
Related Presenters
Filipa Lynce, MD
Medical Oncology
View Profile
Related Videos
Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials
Study of SACI-IO for Triple Negative Metastatic Breast Cancer
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
